Guardant Health stock price target raised to $115 from $61 at Raymond James
PositiveFinancial Markets

Raymond James has raised its price target for Guardant Health's stock from $61 to $115, signaling strong confidence in the company's future performance.
— Curated by the World Pulse Now AI Editorial System







